Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone increases muscle mass regardless of DHT conversion blocking.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Retinoic acid affects male and female muscle energy use and function differently.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Pattern hair loss is mainly caused by genetics and hormones, with limited effective treatments available.

Children with autism have lower levels of essential and toxic trace elements in their hair.

UV light can help stimulate the growth of new pigment cells from hair follicles in people with vitiligo.

New genetic locations explain much of hair color variation in Europeans.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Hidradenitis suppurativa improves with antiandrogen therapy.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Higher androgen levels do not cause baldness in men.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

HDAC6 helps keep ovarian follicles dormant, extending female fertility.

Men and women need different facial rejuvenation treatments due to distinct aging processes and anatomical differences.